A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

Oncolytics Biotech® Inc. , a leading clinical-stage company specializing in immunotherapy for oncology, continues to make good progress in 2025 with key regulatory and clinical advancements, ...

The leading Metastatic Pancreatic Cancer Companies such as Xencor, MEI Pharma, Celldex Therapeutics, TG Therapeutics, ...

The results were impressive. PAC-MANN correctly identified pancreatic cancer in 98% of cases and was able to detect ...

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers.

A new blood test has been found to detect early stage pancreatic cancer with 85% accuracy when used alongside a carbohydrate antigen 19-9 test, according to a study published Feb. 12 in Science ...

He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...

Researchers at Oregon Health and Science University (OHSU) have developed a blood test called PAC-MANN, to detect pancreatic ...

The American Cancer Society estimates that 67,400 Americans will be diagnosed with pancreatic cancer this year and nearly ...

The lab of Dr. Mark Magnuson, Louise B. McGavock Professor and professor of molecular physiology and biophysics at Vanderbilt ...

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...

OHSU's PAC-MANN test offers a breakthrough in pancreatic cancer detection, using a small blood sample to monitor protease ...